Eurofins Scientific (ERF.PA) Stock Price

Eurofins Scientific Price

Euronext·CLOSED
77.12
​
Market closed

Over the last 19 years Eurofins Scientific grew revenue by 17.0% annually, reaching 7.30 B EUR. Earnings per share have grown at 17.6% per year over the last 19 years. For Eurofins Scientific, the net margin of 6.5% is down versus 11.6% a few years ago. At today's price the dividend yield works out to roughly 0.78%. The payout ratio is around 24% of earnings. The dividend has grown at 25.5% per year over the past 18 years. The consensus 12-month price target for Eurofins Scientific is 71.91 EUR, about 6.8% below where the stock trades today. Of 20 analysts, 7 rate the stock a buy — an overall Hold consensus.

Eurofins Scientific stock price

Access this data via the Eulerpool API

Eurofins Scientific business model & stock analysis

Eurofins Scientific SE is a leading group of laboratories specializing in providing testing and analytical services for the food, environment, pharmaceutical, and biopharmaceutical industries. The company was founded in 1987 by Dr. Gilles Martin and is headquartered in Luxembourg. It has since become one of the largest laboratory service providers worldwide. Eurofins' business model is based on a wide range of analytical services that enable customers to monitor product quality, process safety, and regulatory compliance. Eurofins offers a comprehensive range of tests, including food and feed testing, residue analysis, hygiene and contamination analysis, environmental analysis, and genetic testing. The group operates more than 800 laboratories in 47 countries and employs more than 50,000 people. Eurofins has a strong presence in Europe, North America, and the Asia-Pacific region, and is active in various industries such as agriculture and food, environment and pharmaceuticals, as well as clinical diagnostics and forensics. The different divisions of Eurofins are tailored to the specific needs of its customers. For example, the "Food Testing" division offers a wide range of tests to ensure that food is safe and healthy. Thanks to these tests, manufacturers can ensure that their products comply with legal requirements and meet customer needs. Another division of Eurofins is "Environment Testing," which offers tests and analyses for a variety of environmental samples. These enable companies to monitor compliance with environmental regulations, identify environmental issues, and improve their environmental footprint. Eurofins' Biopharma division offers a variety of testing services for the biopharmaceutical industry, including clearance studies, cleaning validation, particle measurements, and DNA sequencing. In the field of clinical diagnostics, Eurofins provides laboratory services to improve diagnoses and treatments. These include genetic testing, oncology tests, prenatal diagnostics, and infectious diseases. Another important business area for Eurofins is forensics, which benefits from the latest developments in DNA analysis as well as analysis methods for detecting drugs, alcohol, and toxic substances. The services provided by Eurofins include forensic wildlife investigations and the identification of human and animal species based on DNA samples. In addition to the aforementioned business areas, Eurofins also offers a wide range of services such as consulting, audits, and training to help improve its customers' performance and help them achieve their business goals. In conclusion, Eurofins Scientific SE is a leading provider of testing and analytical services for the food, environment, pharmaceutical, and biopharmaceutical industries. With its specialized services, the company enables its customers to monitor product quality, process safety, and regulatory compliance. Eurofins' various divisions offer tests and analyses for a variety of industries, contributing to improving its customers' businesses.

Frequently asked questions about Eurofins Scientific

The business model of Eurofins Scientific SE revolves around providing a comprehensive range of laboratory testing services to various industries worldwide. Eurofins Scientific SE offers a wide array of services, including testing and analysis of food, environment, pharmaceuticals, cosmetics, and other materials. With a vast network of laboratories and expertise in different domains, Eurofins Scientific SE caters to the specific needs of its clients, ensuring the highest quality standards are met. By leveraging advanced technology and a strong commitment to innovation, Eurofins Scientific SE positions itself as a leading player in the global testing and scientific services industry, delivering reliable and efficient solutions to its customers.

Eurofins Scientific SE is primarily active in the scientific testing and laboratory services industry. They specialize in providing a wide range of analytical services to various sectors, including food and beverage, pharmaceuticals, environment, biotechnology, and agriscience. With a strong focus on quality and accuracy, Eurofins offers solutions for assessing the safety, quality, and authenticity of products and materials. As a global leader in laboratory testing, Eurofins serves as a trusted partner for businesses, regulatory authorities, and research organizations worldwide.

The main competitors of Eurofins Scientific SE in the market are SGS SA, Bureau Veritas SA, and Intertek Group plc.

Eurofins Scientific SE is a leading global provider of bioanalytical testing services. Established in 1987, Eurofins has evolved into a renowned company specializing in scientific testing, with a broad range of services to support various industries such as food, environmental, pharmaceutical, and cosmetics. With more than 800 laboratories spread across 50 countries, Eurofins offers a comprehensive portfolio of testing methods to ensure safety, quality, and compliance. The company's commitment to innovation, accuracy, and customer satisfaction has earned Eurofins a reputable status in the industry. Eurofins Scientific SE continues to expand its expertise, enhance its capabilities, and provide reliable testing solutions to a diverse range of clients worldwide.

Over the years, Eurofins Scientific SE has achieved several significant milestones. One notable achievement was the company's expansion and acquisition strategy, which helped Eurofins become a leading player in the field of bioanalytical testing services. Additionally, Eurofins Scientific SE received international recognition for its groundbreaking innovations in the areas of food and environment testing. The company's commitment to providing high-quality analytical services and its pursuit of technological advancements have positioned Eurofins as a trusted partner for industries worldwide. Through its continual dedication to excellence, Eurofins Scientific SE has established itself as a prominent global player in the scientific testing and laboratory services industry.

Eurofins Scientific SE is primarily present in numerous countries and regions worldwide. Some of the key locations where the company operates include Europe, North America, Asia-Pacific, Latin America, and Africa. Eurofins has established a strong presence in several European countries such as France, Germany, and the United Kingdom. Additionally, it has expanded its operations across the United States, Canada, China, India, and Brazil, among other countries. With its global footprint, Eurofins Scientific SE ensures a wide geographical coverage to cater to the diverse needs of its customers and clients around the world.

Eurofins Scientific SE is a leading global provider of bioanalytical testing services. The company's values revolve around providing high-quality and reliable results to its clients. Eurofins Scientific SE follows a customer-centric approach and aims to deliver tailored solutions that meet the unique needs of its customers. The company is committed to scientific excellence, innovation, and sustainability. Eurofins Scientific SE also strives for continuous improvement, ensuring that it stays at the forefront of the industry. With a strong dedication to quality, integrity, and customer satisfaction, Eurofins Scientific SE is a trusted partner for businesses across various sectors.

Analysts currently set an average price target of 70.01 EUR for the Eurofins Scientific stock (median: 71.91 EUR), implying -9.2 % versus the latest price. The consensus is based on 20 analyst ratings.

20 analysts currently rate the Eurofins Scientific stock: 7 recommend buying, 11 holding and 2 selling. For 2026, analysts expect Eurofins Scientific to generate revenue of 7.52 B EUR and earnings per share of 4.00 EUR.

The Eurofins Scientific share (ERF.PA) is listed on 13 stock exchanges, including: London (0MV5.L), SIX (Zürich) (ERPS.SW), XETRA (ESF0.DE), Frankfurt (ESF0.F), München (ESF0.MU), Stuttgart (ESF0.SG), Düsseldorf (ESF0.DU), Hamburg (ESF0.HM).

Eurofins Scientific SE is a global company specializing in laboratory services for the analysis of food, environmental samples, and pharmaceutical products. Its business model is based on comprehensive services offered to customers in various sectors. The company operates a wide range of analysis and testing laboratories to ensure products are safe, effective, and compliant with national and international regulations. Eurofins primarily provides services in the field of food safety, testing a variety of foods to confirm their safety. It also offers environmental and water analysis to determine the quality of surface water, drinking water, wastewater, and soil, as well as to assess environmental pollution. Additionally, Eurofins specializes in the analysis of pharmaceutical products to ensure their safety and compliance with international regulations. In addition to these main areas, Eurofins operates laboratories for agriculture, animal health monitoring, and supporting services such as clinical diagnostics and DNA analysis technology. The company continuously invests in research and development of new technologies and methods to improve its services and provide innovative solutions to customer challenges. Overall, Eurofins Scientific SE offers a comprehensive range of laboratory services, specializing in the analysis of food, environmental samples, and pharmaceutical products. It operates multiple laboratories worldwide and strives to provide innovative and effective solutions to customer challenges.

The expected revenue of Eurofins Scientific is 7.52 B EUR. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Eurofins Scientific is 747.37 M EUR. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Eurofins Scientific is currently 19.30. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Eurofins Scientific stock.

The price-to-sales ratio (P/S) of Eurofins Scientific is currently 1.92. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Eurofins Scientific stock.

The Eulerpool Quality Score for Eurofins Scientific is 4/10.

The ISIN of Eurofins Scientific is FR0014000MR3. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Eurofins Scientific is A2QJCT. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Eurofins Scientific is ERF.PA. The ticker symbol is used to trade Eurofins Scientific shares on the stock exchange.

Fair ValueTerminal
70.95 EUR
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Life Sciences Tools & Services
Number of shares
Employees
Revenue per Employee
141,625.90 EUR
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website eurofins.com
Country
Luxembourg
Currency
EUR
Initial public offering
Oct 24, 1997
ISIN
FR0014000MR3
Cusip
L31839134
Sedol
BNDPYV1
Market capitalization
14.42 B EURLarge Cap
52-Week Range
PEG
3.53
P/E ratio
P/Ee 2026
19.30
P/Ee 2027
17.13
P/Ee 2028
15.20
P/Ee 2029
13.88
P/S
P/Se
1.92
EV/EBIT
22.07
P/B Ratio
4.07
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
5.96 %
Dividend
Dividend yield
0.78 %
Est. Dividend Yield
0.93 %
Payout Ratio
23.62 %
Dividend growth Ø5Y
-6.36 %
Dividend payments per year
1
Dividend paid since
5 years
Dividend not reduced since
1 year
Dividend increased since
1 year
Dividend withholding tax
15.00 %
Last updated Oct 12, 2026, 8:37 PM

Eurofins Scientific Peer Group

Eurofins Scientific Ticker

DÜSSELDORF · ESF0.DUEURONEXT · ERF.PAFRANKFURT · ESF0.FHAMBURG · ESF0.HMLONDON · 0MV5.LMUNICH · ESF0.MUPARIS · ERF.PAOTC · ERFSFSIX · ERPS.SWSTUTTGART · ESF0.SGVIENNA · ESF.VIVIENNA · ERF.VI

Eurofins Scientific FIGI

ERF:FP · BBG000BH7B07ESF0:GR · BBG000BMF3F9ESF0:GF · BBG000BMF3T4ESF0:GD · BBG000BMF494ESF0:GY · BBG000BMF4H5ESF0:GS · BBG000BMF4S3ESF0:GM · BBG000BMF5B8ESF0:GB · BBG000BMF608ESF0:GI · BBG000BMF779ESF0:GH · BBG000BMF7S6ERFSF:US · BBG000DL55C8ERFSF:PQ · BBG000DL5FL6